Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
J. bras. nefrol ; 41(1): 103-111, Jan.-Mar. 2019. tab
Artículo en Inglés | LILACS | ID: biblio-1002421

RESUMEN

ABSTRACT One of the mechanisms proposed for chronic kidney disease (CKD)-related cognitive impairment is the accumulation of uremic toxins due to the deterioration of the renal clearance function. Cognition can be categorized into five major domains according to its information processing functions: memory, attention, language, visual-spatial, and executive. We performed a review using the terms 'uric acid', 'indoxyl sulfate', 'p-cresyl sulfate', 'homocysteine', 'interleukins' and 'parathyroid hormone'. These are the compounds that were found to be strongly associated with cognitive impairment in CKD in the literature. The 26 selected articles point towards an association between higher levels of uric acid, homocysteine, and interleukin 6 with lower cognitive performance in executive, attentional, and memory domains. We also reviewed the hemodialysis effects on cognition. Hemodialysis seems to contribute to an amelioration of CKD-related encephalopathic dysfunction, although this improvement occurs more in some cognitive domains than in others.


RESUMO Um dos mecanismos propostos para explicar o comprometimento cognitivo relacionado à doença renal crônica (DRC) é o acúmulo de toxinas urêmicas devido à deterioração da função de depuração renal. A cognição pode ser categorizada em cinco domínios principais de acordo com suas funções de processamento de informações: memória, atenção, linguagem, visual-espacial e executiva. Realizamos uma revisão usando os termos "ácido úrico", "indoxil sulfato", "p-cresil sulfato", "homocisteína", "interleucinas" e "paratormônio". Estes são os compostos que se mostraram fortemente associados ao comprometimento cognitivo na DRC na literatura. Os 26 artigos selecionados apontam para uma associação entre níveis mais elevados de ácido úrico, homocisteína e interleucina-6 com menor desempenho cognitivo nos domínios executivo, atenção e de memória. Também revisamos os efeitos da hemodiálise na cognição. A hemodiálise parece contribuir para uma melhoria da disfunção encefalopática relacionada à DRC, embora essa melhora ocorra mais em alguns domínios cognitivos do que em outros.


Asunto(s)
Humanos , Toxinas Biológicas/efectos adversos , Uremia/complicaciones , Insuficiencia Renal Crónica/complicaciones , Disfunción Cognitiva/etiología , Hormona Paratiroidea/efectos adversos , Ésteres del Ácido Sulfúrico/efectos adversos , Ésteres del Ácido Sulfúrico/sangre , Ácido Úrico/efectos adversos , Ácido Úrico/sangre , Diálisis Renal/efectos adversos , Interleucina-6/efectos adversos , Cresoles/efectos adversos , Cresoles/sangre , Interleucina-1beta/efectos adversos , Interleucina-1beta/sangre , Homocisteína/efectos adversos , Homocisteína/sangre , Indicán/efectos adversos , Indicán/sangre
2.
Int. braz. j. urol ; 39(1): 63-76, January-February/2013. tab, graf
Artículo en Inglés | LILACS | ID: lil-670379

RESUMEN

Purpose The objective of the study was to evaluate the synergistic transdermal permeation effect of chemical enhancers and iontophoresis technique on tolterodine tartrate (TT) transdermal gel and to evaluate its pharmacokinetic properties. Materials and Methods Taguchi robust design was used for optimization of formulations. Skin permeation rates were evaluated using the Keshary-chein type diffusion cells in order to optimize the gel formulation. In-vivo studies of the optimized formulation were performed in a rabbit model and histopathology studies of optimized formulation were performed on rats. Results Transdermal gels were formulated successfully using Taguchi robust design method. The type of penetration enhancer, concentration of penetration enhancer, current density and pulse on/off ratio were chosen as independent variables. Type of penetration enhancer was found to be the significant factor for all the responses. Permeation parameters were evaluated when maximum cumulative amount permeated in 24 hours (Q24) was 145.71 ± 2.00µg/cm2 by CIT4 formulation over control (91.89 ± 2.30µg/cm2). Permeation was enhanced by 1.75 fold by CIT4 formulation. Formulation CIT4 containing nerolidol (5%) and iontophoretic variables applied (0.5mA/cm2 and pulse on/off ratio 3:1) was optimized. In vivo studies with optimized formulation CIT4 showed increase in AUC and T1/2 when compared to oral suspension in rabbits. The histological studies showed changes in dermis indicating the effect of penetration enhancers and as iontophoresis was continued only for two cycles in periodic fashion so it did not cause any skin damage observed in the slides. Conclusion Results indicated that iontophoresis in combination with chemical enhancers is an effective method for transdermal administration of TT in the treatment of overactive bladder. .


Asunto(s)
Animales , Masculino , Conejos , Ratas , Compuestos de Bencidrilo/farmacocinética , Cresoles/farmacocinética , Iontoforesis/métodos , Fenilpropanolamina/farmacocinética , Vejiga Urinaria Hiperactiva/tratamiento farmacológico , Agentes Urológicos/farmacocinética , Administración Cutánea , Compuestos de Bencidrilo/administración & dosificación , Compuestos de Bencidrilo/sangre , Cresoles/administración & dosificación , Cresoles/sangre , Sinergismo Farmacológico , Geles , Modelos Animales , Fenilpropanolamina/administración & dosificación , Fenilpropanolamina/sangre , Ratas Wistar , Reproducibilidad de los Resultados , Absorción Cutánea , Factores de Tiempo , Resultado del Tratamiento , Agentes Urológicos/administración & dosificación , Agentes Urológicos/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA